-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Outlook Therapeutics, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2015 to 2023.
- Outlook Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending December 31, 2022 was $1.16M, a 5650% increase year-over-year.
- Outlook Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $1.16M, a 25.5% decline from 2022.
- Outlook Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $1.56M, a 3267% increase from 2021.
- Outlook Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $46.2K, a 94.9% decline from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)